Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation

Table 1

Donor and recipient characteristics.

	Group low ()	Group high ()	Significance
Donor
Age (SD)	52.3 ± 15	51.5 ± 16	n.s.
Gender (M/F, %)	55.3/44.7	51.1/48.9	n.s.
BMI > 28 (%)	15.2	12	n.s.
Preservation solution
(UW/Custodiol/other, %)	48/52/0	60/48.4/0.6
DRI (mean, SD)	1.67 ± 0.37	1.7 ± 0.39	n.s.
Cold ischemia time (min, mean ± SD)	504 ± 185	519 ± 157	n.s.
Cause of death
Trauma (%)	13.16	10.55
Anoxia (%)	13.16	8.73
Cerebrovascular accident (%)	65.79	60
Other (%)	7.89	20.73
Recipient
Age	53.5 ± 10	50.7 ± 12.4	n.s.
MELD (mean)	9	20.5	0.001
Diagnosis
Hepatocellular cancer, other tumors (%)	29.6	7.2	0.001
Postviral cirrhosis (%)	37.5	23.6	0.01
Sclerosing cholangitis (%)	19.1	21.8	0.05
Primary biliary cirrhosis (%)	2	10	0.01
Laennec cirrhosis (%)	15.8	17	n.s.
Cryptogenic cirrhosis (%)	6.6	8.3	n.s.
Acute hepatic failure (%)	0.6	7.3	0.01
Retransplantation (%)	6.6	12	n.s.
Other (%)	19.8	11
Surgical technique
Standard OLT	5.3	2.9	n.s.
OLT with venovenous bypass	19.7	26.9	n.s.
Piggyback technique	75	70.2	n.s.